Jurisdiction: United States District Court for the District of Oregon Plaintiffs Robert and Delores Thrasher sued 42 defendants alleging that Robert Thrasher’s asbestos exposure as a child in Oregon and in his Navy service led to his mesothelioma. They …

… strain. Unlike more common illnesses, mesothelioma typically requires specialized care, long …  limited to medical bills. Many mesothelioma patients experience significant income loss … , qualify for subsidies, or access grants that offset treatment costs. For …

Court: United States District Court for the Eastern District of Louisiana In this action, Plaintiff Jerry Lejeune alleges occupational asbestos exposure as a deckhand and/or driller for various employers at job sites in Louisiana, beginning in 1973.  …

Jurisdiction: United States District Court for the Eastern District of Louisiana The district court granted a motion to compel filed by defendant, Illinois Central Railroad Company, to take the blood sample of plaintiff Gael Garon. Plaintiff alleges she …

PRINCETON, N.J.--(BUSINESS WIRE)--Dec 11, 2025-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to the supplemental Biologics License Application (sBLA) for Opdivo …

Jurisdiction: United States District Court for the Eastern District of Louisiana Decedent Michael Dandry Jr. was employed in various positions by defendant, Avondale, between June 1971 and August 1971. During that time, plaintiffs claim decedent was …

… to be diagnosed with malignant mesothelioma in November 2022.  Plaintiffs … caused Mr. Wright’s mesothelioma and therefore dismissal of … prolonged latent diseases like mesothelioma or asbestosis. To prove … had already determined to grant Mack summary judgment on …

The U.S. Food and Drug Administration (FDA) has granted fast track designation to VT3989, a novel investigational small molecule cancer therapeutic, for the treatment of patients with unresectable malignant nonpleural or pleural mesothelioma whose disease …

The FDA has granted fast track designation to VT3989, a transcriptional enhanced associate domain (TEAD) autopalmitoylation inhibitor, for the treatment of patients with unresectable malignant nonpleural or pleural mesothelioma who have progressed on prior …

… hazard” that can eventually cause mesothelioma. Johnson & Johnson Plans to … talcum products don’t cause mesothelioma, ovarian cancer or other asbestos … program. Access Trust Funds, Grants & Compensation for Mesothelioma Get Financial Assistance